BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-196@pharmaconomics
DTSTAMP:20260707T034241Z
DTSTART;VALUE=DATE:20260630
DTEND;VALUE=DATE:20260701
SUMMARY:CAPR Phase 1 — StealthX (estimated date)
DESCRIPTION:Phase 1 trial results for StealthX in its lead indication are due ~ Jun 30\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1133869/000110465926027037/capr-20260312xex99d1.htm\n\nTrack it: https://www.pharmaconomics.com/e/196
URL:https://www.pharmaconomics.com/e/196
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:CAPR catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR